Skip to main content

Chronic obstructive pulmonary disease with lung cancer: Prevalence, severity, and common pathogenesis

Published: 25 January 2016

A new study published on the Journal of Cancer Research and Therapy focuses on the relationship between COPD and lung cancer.

The aim of this study is to develop a clinical prediction model of contribution of chronic obstructive pulmonary disease (COPD) to the pathogenesis of lung cancer, by reporting the estimated prevalence and severity by GOLD criteria in a single-institution cohort of patients with newly diagnosed lung cancer.

Primary objective was investigating the effects of impaired lung function with various histological cell types on crude survival, while considering the initial staging of disease extent.

The study results confirm that the presence and severity of COPD in lung cancer patients is an independent predictor of survival time, different from the established staging of initial extent of disease.

The study is available free to download at the following link: click here

Get in touch

COSMED strives to provide the best service possible with every contact!

Fill the online forms to get the info you're looking for right now!

Register your Product

Register your Product

Fill the online form to get software upgrades and more advantages

Read more

Request for information

Request for information

Fill the online form to get more information or a quote 

Read more

Request for Support

Request for Support

Fill the online form in order to help us fully understand your problem

Read more

COSMED LOGO
COSMED LOGO

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

FOLLOW US ON

FOLLOW US ON